Modeled changes in CD4 count for surviving patients initiating antiretroviral therapy during 2004–2007.

<p>Modeled changes in CD4 count for surviving patients initiating antiretroviral therapy during 2004–2007.</p

Modeled changes in weight over time for surviving patients initiating ART during 2004–2007.

<p>Modeled changes in weight over time for surviving patients initiating ART during 2004–2007.</p

Patient characteristics at antiretroviral therapy initiation associated with attrition and treatment failure.

<p>Abbreviations: Rate/100PY, rate per 100 person-years; HR, hazards ratio; AHR, adjusted hazards ratio; CI, confidence interval; TB, tuberculosis; WHO, World Health Organization; BMI, body mass index; CTX, co-trimoxazole.</p><p>*Stratified by CD4⁺ T-cell count (cells/µL).</p>†<p>All variables listed in this table were included in the multivariate Cox proportional hazards regression model.</p><p>**Hazard ratios associated with a 10-year increase in age.</p>‡<p>Date of ART initiation was entered into the model; hazard ratios represent a yearly increase rather than a daily increase.</p

TB Incidence Rates during ART Follow-up among Patients Assessed as TB-free at ART Initiation (n = 2,325).

<p>TB Incidence Rates during ART Follow-up among Patients Assessed as TB-free at ART Initiation (n = 2,325).</p

Kaplan-Meier Analysis (imputed dataset 1).

<p>Kaplan-Meier Analysis (imputed dataset 1).</p

Kaplan Maier Analysis of TB-Free Survival.

<p><b>A</b> Kaplan Meier Curve of TB Incidence Stratified by Baseline Weight. <b>B</b> Kaplan Meier Curve of TB Incidence Stratified by Level of ART Adherence. <b>C</b> Kaplan Meier Curve of TB Incidence Stratified by TB Screening at ART Start.</p

Associations between Patient Characteristics and Prevalence of Active TB at ART Initiation.

<p>Abbreviations: TB, tuberculosis; ART, antiretroviral therapy; IQR, inter-quartile range; CI, 95% confidence interval; WHO, World Health Organization; CTX, Co-trimoxazole; d4T, stavudine; AZT, zidovudine; 3TC, lamivudine; NVP, nevirapine; EFV, efavirenz; ABC, abacavir.</p>*<p>Data in this column has been previously published <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0054665#pone.0054665-Auld1" target="_blank">[14]</a>.</p>**<p>Compares characteristics of patients receiving (n = 271) and not receiving (n = 2,325) TB treatment at ART initiation.</p

Cox Proportional Hazards Analysis of Patient Characteristics Associated with TB Incidence during ART Follow-up.

<p>Abbreviations: HR, hazards ratio; AHR, adjusted hazards ratio; TB, tuberculosis; CI, confidence interval; WHO, World Health Organization; CTX, Co-trimoxazole.</p>*<p>Hazard ratio is reported for every 10 year increase in age at ART start.</p

Compliance with TB Screening at ART Enrollment by Clinic and Supporting Non-Governmental Organization.

<p><b>A</b> Compliance with TB Screening Guidelines According to ART Clinic (n = 2,596). <b>B</b> Compliance with TB Screening Guidelines According to Primary Non-Governmental Agency Supporting the ART Clinic (n = 2,596).</p

Cumulative incidence of LTFU and Death among matched CASG and non-CASG participants.

<p>Cumulative incidence of LTFU and Death among matched CASG and non-CASG participants.</p